Clinical Trials Browser

Phase 2 × Recurrence × Ribavirin × Clear all

NCT00559091 2022-12-22

Borden-001

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute